Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids
Autor(a) principal: | |
---|---|
Data de Publicação: | 2009 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/18013 |
Resumo: | OBJECTIVES: The etiology of osteoporosis in asthma is complex as various factors contribute to its pathogenesis. The purpose of our study was to investigate the effects of obesity and inhaled steroids, as well as the severity and duration of asthma, on osteoporosis in postmenopausal asthma patients as compared to healthy controls. METHODS: A total of 46 patients with asthma and 60 healthy female controls, all postmenopausal, were enrolled in our study. Bone mineral density was assessed at the lumbar spine and hip using a Lunar DPX-L densitometer. RESULTS: Bone mineral density (BMD) scores were comparable between the asthmatic and control groups, with average scores of 0.95 ± 0.29 and 0.88 ± 0.14 g/cm², respectively. Likewise, osteoporosis was diagnosed in a similar percentage of patients in the asthmatic (39.1%) and control (43.3%) groups. Bone fracture was identified in four patients with asthma (8.6%) and in six patients from the control group (10%). We could not detect any relationship between BMD and duration of asthma, asthma severity, inhaled steroids or body mass index (BMI). There was no difference between the two groups with respect to age or years since menopause. Although asthma patients were more likely to be overweight and presented higher BMD scores on average than the control subjects, these differences were not statistically significant. CONCLUSIONS: There is a slight positive protective effect of high BMI against osteoporosis in asthma patients, but this effect is overcome by time and menopause status. Therefore, the protective effect of obesity against osteoporosis in asthma patients seems to not be significant. |
id |
USP-19_81c1000132b504878c2a5820fad392e2 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/18013 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids AsthmaObesityOsteoporosisBone mineral densitometryInhaled steroids OBJECTIVES: The etiology of osteoporosis in asthma is complex as various factors contribute to its pathogenesis. The purpose of our study was to investigate the effects of obesity and inhaled steroids, as well as the severity and duration of asthma, on osteoporosis in postmenopausal asthma patients as compared to healthy controls. METHODS: A total of 46 patients with asthma and 60 healthy female controls, all postmenopausal, were enrolled in our study. Bone mineral density was assessed at the lumbar spine and hip using a Lunar DPX-L densitometer. RESULTS: Bone mineral density (BMD) scores were comparable between the asthmatic and control groups, with average scores of 0.95 ± 0.29 and 0.88 ± 0.14 g/cm², respectively. Likewise, osteoporosis was diagnosed in a similar percentage of patients in the asthmatic (39.1%) and control (43.3%) groups. Bone fracture was identified in four patients with asthma (8.6%) and in six patients from the control group (10%). We could not detect any relationship between BMD and duration of asthma, asthma severity, inhaled steroids or body mass index (BMI). There was no difference between the two groups with respect to age or years since menopause. Although asthma patients were more likely to be overweight and presented higher BMD scores on average than the control subjects, these differences were not statistically significant. CONCLUSIONS: There is a slight positive protective effect of high BMI against osteoporosis in asthma patients, but this effect is overcome by time and menopause status. Therefore, the protective effect of obesity against osteoporosis in asthma patients seems to not be significant. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2009-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/1801310.1590/S1807-59322009000400008Clinics; Vol. 64 No. 4 (2009); 313-318 Clinics; v. 64 n. 4 (2009); 313-318 Clinics; Vol. 64 Núm. 4 (2009); 313-318 1980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/18013/20078Yanik, BurcuAyrim, AylinOzol, DuyguKoktener, AsliGokmen, Deryainfo:eu-repo/semantics/openAccess2012-05-22T18:51:19Zoai:revistas.usp.br:article/18013Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2012-05-22T18:51:19Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids |
title |
Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids |
spellingShingle |
Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids Yanik, Burcu Asthma Obesity Osteoporosis Bone mineral densitometry Inhaled steroids |
title_short |
Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids |
title_full |
Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids |
title_fullStr |
Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids |
title_full_unstemmed |
Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids |
title_sort |
Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids |
author |
Yanik, Burcu |
author_facet |
Yanik, Burcu Ayrim, Aylin Ozol, Duygu Koktener, Asli Gokmen, Derya |
author_role |
author |
author2 |
Ayrim, Aylin Ozol, Duygu Koktener, Asli Gokmen, Derya |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Yanik, Burcu Ayrim, Aylin Ozol, Duygu Koktener, Asli Gokmen, Derya |
dc.subject.por.fl_str_mv |
Asthma Obesity Osteoporosis Bone mineral densitometry Inhaled steroids |
topic |
Asthma Obesity Osteoporosis Bone mineral densitometry Inhaled steroids |
description |
OBJECTIVES: The etiology of osteoporosis in asthma is complex as various factors contribute to its pathogenesis. The purpose of our study was to investigate the effects of obesity and inhaled steroids, as well as the severity and duration of asthma, on osteoporosis in postmenopausal asthma patients as compared to healthy controls. METHODS: A total of 46 patients with asthma and 60 healthy female controls, all postmenopausal, were enrolled in our study. Bone mineral density was assessed at the lumbar spine and hip using a Lunar DPX-L densitometer. RESULTS: Bone mineral density (BMD) scores were comparable between the asthmatic and control groups, with average scores of 0.95 ± 0.29 and 0.88 ± 0.14 g/cm², respectively. Likewise, osteoporosis was diagnosed in a similar percentage of patients in the asthmatic (39.1%) and control (43.3%) groups. Bone fracture was identified in four patients with asthma (8.6%) and in six patients from the control group (10%). We could not detect any relationship between BMD and duration of asthma, asthma severity, inhaled steroids or body mass index (BMI). There was no difference between the two groups with respect to age or years since menopause. Although asthma patients were more likely to be overweight and presented higher BMD scores on average than the control subjects, these differences were not statistically significant. CONCLUSIONS: There is a slight positive protective effect of high BMI against osteoporosis in asthma patients, but this effect is overcome by time and menopause status. Therefore, the protective effect of obesity against osteoporosis in asthma patients seems to not be significant. |
publishDate |
2009 |
dc.date.none.fl_str_mv |
2009-04-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/18013 10.1590/S1807-59322009000400008 |
url |
https://www.revistas.usp.br/clinics/article/view/18013 |
identifier_str_mv |
10.1590/S1807-59322009000400008 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/18013/20078 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 64 No. 4 (2009); 313-318 Clinics; v. 64 n. 4 (2009); 313-318 Clinics; Vol. 64 Núm. 4 (2009); 313-318 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222754718351360 |